Progesterone Resistance Clinical Trial
— ProthreatOfficial title:
Progesterone Supplementation in Threatened Abortion: Is it a Sound Practice?
Verified date | July 2023 |
Source | Tanta University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To decide whether progesterone supplementation in threatened abortion is a sound practice.
Status | Completed |
Enrollment | 190 |
Est. completion date | December 31, 2018 |
Est. primary completion date | December 31, 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 20 Years to 40 Years |
Eligibility | Inclusion Criteria: - threatened abortion diagnosed by history and ultrasound examination - singleton - viable fetus - gestational age < 20 weeks - closed normal length cervix. Exclusion Criteria: - short cervix <2 cm Multiple pregnancy - dead fetus - open cervix = 2cm - history of cervical surgery - refusal to participate. |
Country | Name | City | State |
---|---|---|---|
Egypt | Ayman Shehata Dawood | Tanta |
Lead Sponsor | Collaborator |
---|---|
Tanta University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | relief of pain | questionnaire fulfilled by patient with yes or no questions | 3 weeks | |
Primary | completion of pregnancy beyond 20 weeks | passing the age 20 weeks | 12 weeks | |
Primary | Stoppage of bleeding | Cessation of bleeding | 3 weeks | |
Secondary | abortion less than 20 weeks. | Abortion | 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03356964 -
Step Down FSH Approach and Late Follicular Phase in Progesterone Level
|
Early Phase 1 | |
Completed |
NCT03519776 -
Variation of Progesterone in IVF Cycles
|
||
Recruiting |
NCT06379113 -
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
|
Phase 2/Phase 3 | |
Recruiting |
NCT05316935 -
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
|
Phase 2/Phase 3 | |
Recruiting |
NCT06390904 -
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients
|
Phase 2/Phase 3 | |
Completed |
NCT05062135 -
Progesterone Action on Endometrium of PCOS
|
N/A |